ESMO BREAST CANCER 2020

Start

Thu, 7 May 2020, 09:00

End

Sat, 9 May 2020, 06:00

WebSite

https://iii.hm/11se

Hashtag:

#ESMOBC20

Venue:

ESMO BREAST CANCER 2020 HAS BEEN CANCELLED DUE TO COVID-19 HEALTH CONCERNS

Find ESMO on Social Media

Exhibit

Symposia

Workshops

Organiser

Sponsor

Following up on the successful first edition of ESMO Breast Cancer, we are proud to announce that ESMO Breast Cancer 2020 will take place on 7-9 May 2020 in Berlin, Germany.

Cancer patients and their needs are at the heart of what we do – we are committed to advancing research and integrating it into the clinic to ensure better care for our patients.

Our aim is to deliver a comprehensive overview of all the practice-changing new data and to make sure it has a clear roadmap to the clinic.

Save the date for ESMO Breast Cancer, a multidisciplinary meeting where you will learn how to integrate innovation into your daily practice and improve patient care.

Learning objectives

To spread knowledge by interaction and networking across breast cancer specialists, worldwide and across disciplines
To train breast cancer specialists by international breast cancer key opinion leaders
To integrate translational research into cancer care and practice
To improve precision medicine as part of breast cancer treatment
To promote “omics”, “artificial intelligence” and “big data” integration in the field of breast cancer
To improve immunotherapy approach in the breast cancer field
To design the next generation clinical trials of the next decade
To explore pathways for drug discovery and development: From next generation genomics to next generation therapies

Audience

ESMO Breast Cancer is a congress designed for breast cancer researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and care. It will be a multidisciplinary meeting with a global scope, involving top scientists and taking place in Europe.

Accreditation

ESMO-MORA: The ESMO Breast Cancer 2020 programme will be submitted for ESMO-MORA category 1 points accreditation. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.

Webcasts

The congress webcasts will include all the sessions of the official programme, where speaker permission is granted, and will be available on this website and on OncologyPRO for ESMO members.